Personalising therapy for early-stage oestrogen receptor-positive breast cancer in older women

Personalising therapy for early-stage oestrogen receptor-positive breast cancer in older women

Summary: Age is one of the most important risk factors for the development of breast cancer. Nearly a third of all breast cancer cases occur in older women (aged ≥70 years), with most cases being oestrogen receptor-positive (ER+). Such tumours are often indolent and unlikely to be the ultimate cause...

Full description

Bibliographic Details
Main Authors: Neil Carleton, BS, Azadeh Nasrazadani, MD, Kristine Gade, MD, Sushil Beriwal, MD, Parul N Barry, MD, Adam M Brufsky, ProfMD, Rohit Bhargava, ProfMD, Wendie A Berg, ProfMD, Margarita L Zuley, ProfMD, G J van Londen, MD, Oscar C Marroquin, MD, Darcy L Thull, MS, Phuong L Mai, MD, Emilia J Diego, MD, Michael T Lotze, ProfMD, Steffi Oesterreich, ProfPhD, Priscilla F McAuliffe, MD, Adrian V Lee, ProfPhD
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:The Lancet. Healthy Longevity
Online Access:http://www.sciencedirect.com/science/article/pii/S2666756821002804

Internet

http://www.sciencedirect.com/science/article/pii/S2666756821002804

Similar Items